Impact of Nucleos(t)ide Analogs on Major Clinical Outcomes in Patients With Chronic Hepatitis B: A 10‐Year French Nationwide Cohort Study
Tenofovir was associated with a higher risk of HCC compared with entecavir, although no difference in the composite outcome of mortality or liver-related events was observed between the two treatments.
Authors
- Marc Bourlière (ORCID: https://orcid.org/0000-0001-8976-9200)
- Laurent Lam (ORCID: https://orcid.org/0000-0003-3857-9604)
- Stanislas Pol (ORCID: https://orcid.org/0000-0001-9772-9591)
- Fabrice Carrat (ORCID: https://orcid.org/0000-0002-8672-7918)
Institutions
- Inserm (FR)
- Université Paris Cité (FR)
- Aix-Marseille Université (FR)
- Sorbonne Université (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Saint-Antoine (FR)
- Hôpital Saint Joseph (FR)
- Groupe Hospitalier Cochin - Port-Royal, Hôtel-Dieu, Broca - La Collégiale (FR)
- Institut Pierre Louis d‘Épidémiologie et de Santé Publique (FR)
- Economic & Social Sciences, Health Systems & Medical Informatics (FR)
- Institut de Recherche pour le Développement (FR)
Publication Details
- Journal
- Alimentary Pharmacology & Therapeutics
- Published
- 2024-12-31
- DOI
- https://doi.org/10.1111/apt.18462
- Citations
- 1
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.39